MAPT and Alzheimer disease: Two more probes (3g and 3h) with better fluorescence emission upon tau aggregates binding (λem = 650 nm) have been proposed (Seo et al., 2016); in this case, probe selectivity was tested both in vitro and on AD human brain slices.